.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Argus Health
US Department of Justice
UBS
Fuji
McKesson
Chubb
Harvard Business School
Accenture

Generated: February 21, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 05101467

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Gilead Sciences IncCOMPLERAemtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarateTABLET;ORAL202123-001Aug 10, 2011RXYesYes➤ Sign Up➤ Sign UpY
Gilead Sciences IncODEFSEYemtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarateTABLET;ORAL208351-001Mar 1, 2016RXYesYes➤ Sign Up➤ Sign UpY
Janssen ProdsEDURANTrilpivirine hydrochlorideTABLET;ORAL202022-001May 20, 2011RXYesYes➤ Sign Up➤ Sign UpY
Viiv HlthcareJULUCAdolutegravir sodium; rilpivirine hydrochlorideTABLET;ORAL210192-001Nov 21, 2017RXYesYes➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist